Clinical Trials

Phase I/II Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) With Versus Without Etoposide in Older Patients With Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin’s Lymphoma

France

OBJECTIVE: Compare the complete response rates and overall survival in older patients with diffuse large B-cell or peripheral T-cell non-Hodgkin’s lymphoma treated with CHOP with vs without etoposide.

ELEGIBILITY REQUIREMENTS: Diagnosis of diffuse large B-cell or peripheral T-cell non-Hodgkin’s lymphoma. Age 70 and over. No history of concurrent severe disease or other concurrent use of antineoplastic agents.

CONTACT INFORMATION:
EORTC Lymphoma Group
Pierre Soubeyran MD PH: 33-5-56-33-32-67
Soubeyran_p@bergonie.org
Bordeaux, FRANCE

8am to 5pm EST

English French German Italian Portuguese Russian Spanish

This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.